A study to assess the Effectiveness of structured teaching programme on

knowledge regarding Covid 19 among children at selected community area

Lucknow.

Submitted by –

Ms. Annpurna yadav

Ms. Nidhi shukla

Ms. Punam pal

Ms. Pooja yadav

Research project submitted to the Indira Gandhi School and College of

Nursing,
Lucknow
In partial fulfilment of the requirement for Degree of the B.Sc. (N)
Under the guidance of
Ms. Rachana sen
Lecturer
 CERTIFICATE BY THE GUIDE

This is to certify that that research project entailed ‘’A study to assess the
effectiveness of structured teaching program on knowledge and attitude
regarding COVID-19 among student in selected community area munshiganj
Amethi’’is a bonafide research work done by –
Miss. Annapurna Yadav
Miss. Nidhi Shukla
Miss. Pooja Yadav
Miss. Poonam Pal
Partial fulfillment of requirement for the degree of BSc. Nursing.
Date-
Place- Signature of
Principal-
 CERTIFICATE BY THE INSTITUTION
This is to certify that the research project entailed ‘’A study to assess the
effectiveness of structured teaching program on knowledge regarding COVID-
19 among children in selected community area Munshiganj Amethi, is bonafide
research work done by-,
Miss. Annapurna Yadav
Miss. Nidhi Shukla
Miss. Pooja Yadav
Miss. Poonam Pal.

Seal and signature of guide- Miss. Rachna

Sen.

Seal and signature of principal- Dr. Elakkuana Bhashkara

Raj.
 ACKNOWLEDGEMENT

We own my gratitude to the almighty who makes everything possible in our

lives, for his faithfulness and countless blessing during the
Entire course of study and completion of this work.
We extend our heartful thanks to Managing trustee, Indira Gandhi
School and College of Nursing who was the motivation and constant support to
complete this course and upAlift in my profession.
We are grateful to Prof.Elakkuvana Bhaskara Raj, Principal Indira
Gandhi school and college of Nursing for guidance and encouragement dusring
the course and completion of this study.
We are indeed grateful to Mrs.Nima V P, Associate professor
Indira Gandhi School and college of Nursing for her tireless effort, expert
suggestion and constant guidance throughout the course and completion of this
study.
We take this opportunity to thank the entire teaching staff, Indira
Gandhi School and college of Nursing for their contribution throughtout the
course.
We thank all the postnatal women who participated in this study.
Date:
AnnpurnaYadav

Nidhi Shukla

Punam pal

Pooja Yadav
Place:

ABSTARCT

Background of the study-COVID-19 is a infectious disease caused by severe

acute respiratory syndrome corona virus (SARS-COV-2) (China WHO in
mission 2020). The disease was 1st. identified in 2019 in WUHAN the capital
of HUBAI China and has since spread globally, resulting in the 2019-2020
corona virus pandemic.
The common symptoms of COVID-19 include –
fever, dry cough, and difficulty in breathing, muscle pain, sputum production
and sore throat (center for disease control and prevention 2020). While the
majority of causes result in mild symptoms, some progress to pneumonia and
multi organ failure.
 In the month of march from 0.2-15% according to
age group and other health problem, until the preparation of this proposal more
than 1,010,000 cases of COVID-19 have been reported in more than 2000
countries and territories, resulting in over 53,000 deaths but more than 211,000
people have recovered from the daily virus.
Since the report of cases from BHUAN, a city in
the HUBAI in China, at the end of COVID-19, more than 80,000 COVID -19
cases have been reported in China, with the majority of those from HUBAI and
surrounding provinces. A joint WHO China fact-finding mission estimated that
that epidemic in china peaked between late January and early February 2020
and the role of new cases decreased substantially by every March.
However, at present time cases have been
reported in all continents except for Antarctic and have been rapidly rising in
many countries of the world’s. the rapid interview of the cases of COVID-19
throughout the world including the united states, most countries inventers
Europe and recently it has been reported in SOUTH EAST ASHIA and this has
forced the country to announced sudden lockdown.
The virus was typically spread from one person
to another person via respiratory droplets produce during coughing, sneezing
etc., it may also be spread from touching contaminated surface and then
touching once face. The virus can live surface up to 72 hours. The time from
exposure to onset of symptoms is generally between 2 or 14 days, with an
average of 5 days. The standard method of diagnosis is by reverse transcription
polymerase chain reaction from a NOSOPHARYNGEAL swab. The infection
also can be diagnosed from a combination of symptoms, risk factors and a
chest CT scan showing feature of pneumonia.
The recommended measure to prevent infection
include frequent hand washing, social distancing, and keeping hand away from
face. The use of sanitized mask is recommended for suspect person and their
caregiver but not for the general public although simple cloths mask may be
used who desire them. And used COVID vaccine to prevent covid infection.

INDEX
CHAPTER CONTENT PAGE NO

1 Introduction

2 Review of
literature

3
Methodology

4
Result

Discussion
5

Summary
6

Conclusion
7

Bibliography
8

Annexure
9
 TABLE CONTENT
TABLE NO DESCRIPTION PAGE NO

1
To assess the demographic variables
knowledge regarding covid 19 among
children

To assess pretest level knowledge

2 regarding covid 19

3 To assess posttest level of knowledge

on covid 19 among children

4 Pretest posttest effectiveness

5 To Compare between pretest and

posttest level of knowledge on covid
19 among children

To associate the knowledge of covid

6 19 among children
 CHAPTER -I

INTRODUCTION
BACKGROUND OF THE STUDY
COVID-19 is an infection disease caused by severe acute respiratory
syndrome corona virus (SARS-cov2) (china WHO) mission 2020)
the disease was first identified in2019 in Wuhan the capital of Hubei
china and has since spread globally resulting in the 2019 -20 corona
virus pandemic. The common symptoms of Covid -19 include fever,
dry cough and difficulty in breathing but muscle pain sputum
production diarrhoea and sore throat are less common [centre for
disease control and prevention 2020] while the majority of cases
result in mild symptom, some progress to pneumonia and multi
organ failure.

In the month of march from 0.2% to 15 according to age group and

health problem, until the preparation of this proposal, more than
1,010,000 cases of covid-19 have been reported in more than two
hundred countries and territories, resulting in over 53000 deaths but
more than 211000 people have recovered from the delay virus.

Since the report of cases from Wuhan, a city in the Hubei province
of china, at the end of 2019, more than 80,000 covid-19 cases have
been reported in china, with the majority of those from Hubei and
surrounding provides. A Joints WHO China fact –finding mission
estimate that the epidemic in China peaked between late January and
early February 2020 and the role of new cases decreased
substantially by early march.

However, at present time cases have been reported in all continents

except for Autarkical and have rapidly rises in many countries of the
world. The rapid increment of the cases of scovid-19 throughout the
world including the united states, most countries investor Europe
and recruit it has been reported in Souter east Asia and this has
forced the countries to announces sudden lockdown.

The virus is typically spread from one person to another via

respiratory droplets procedure during coughing. [prevention]. It may
also be spread from touching contaminated surface and then
touching one’s face. The virus can live on surface up to 72 hours.

The time from exposure to onset of symptoms is generally between

two and fourteen days. With an average of five days. The standard
method of diagnosis is by reverse transcriptions polymer chain
reaction from a nasopharyngeal swab. The infection cause also is
diagnosis from a combination of symptoms, risk factor and a chest
CT scan showing features of pneumonia.

The recommended measure to prevent infection includes frequent

hand washing, social distancing and keeping hand away from face.
The one of sanitized marks is recommended for suspect person and
their caregivers but not for the general public although simple cloths
marks may be used by those who desire them.

Publishes international research on development studies including

social sciences economics hand law with a focus on Nordic
countries.
 The ICMR Could have instituted a dedicated cell for basic research
to understand the features of the COVID 19 epidemic in India – for
example, rapid genomics to understand the virus make –up and its
evolution, the significance of antibody responses in COVID
Infection and the protective CO- relate of the human response to
COVID-19.

This knowledge will contribute significantly to our survival in the

next pandemic when it comes. not a question of ‘’if’’.

The writer is with the foundation for medical research Mumbai

The recovering Chinese population in Wuhan, on many of whom

such retrospective data would been recorded, would be an excellent
source for the studies of the above-mentioned issues. such studies
would give an impetus to the creation of a viral repository. Do our
national agencies such as the ICMR and department of
Biotechnology have repository that is complete with valuable
metadata.

Whilst we fight the epidemic with conventional measures, the search

for helpful

knowledge

that Illuminates how our species and other protected species

react to COVID-19 over

time hold not be belittled or protects against viral and bacterial

infection

] response.

Moreover, a deep study of viral genomics from viral isolates form

such individual would be salutary. Are these isolates any different
from those that infect individuals who have increased severity of
symptoms, normalised for age and health profiles/.
If do rigorous surveillance in the country, in all likelihood, we
would find that individuals with no overt, or extremely mild,
symptoms are in a carrier or quasi carrier state. It would be logical
to hypothesise that these would be young people , healthy enough
to not fall spray to the cytokine storm set off by the virus , but not
capable of preventing the spread of the virus , what would be their
health profile and reasons for their health immunity , Could we not
pick up correlates of protective immunity from these individuals
which would help in the evaluation of a vaccine- apart from a robust
IgG [The antibody the protects against viral and bacterial before
testing is obscure in many localities .In line with the
recommendation of Harvard University’s Ashish jha , an
epidemiology –based random sampling of asymptomatic individuals
in parts of COVID19 clusters may yield a better picture of the extent
of community transmission . such sampling might also yield better
insights into the Indian epidemic.

NEED OF THE STUDY

A study conducted in china during the initial outbreak of Covid 19

found that 53.8 of rated psychological impact of the outbreak 16.5%
reported moderate to severe depression 28.8% reported moderate to
severe anxiety and 0.1% reported moderate to severe stress level.

The following are ongoing and completed covid-19 studies listed on

the WHO international clinical trials registry platform. Information
in WHO ICTPR coma from clinical trial data based maintained by
others countries of the world. Covid-19 studies listed on clinical04-
94--wq trials are not includes in the list below but can be found
using our search for covid-19.
 In Indian council of medical research has transitioned from
dismissing community transmissions into accepting that it could be a
reality. A big gap in our knowledge of covid-19 is the variety of
immune response that is may engender in different individual and
the operability of presence of viral caries.

As reported by researchers from symptomatic infections were first

seen in china and then in Germany and Italy. They were measured to
be 55% less contagious than those with symptoms but, they were
shown to be the source of nearly 80% of all infections

While we fight the epidemic with conventional measure, Search for

helpful knowledge that illuminated how our species and others
protected species react to covid-19 over species react to covid-19
over a period of time should not to belittled.

The ICMR could have instituted a dedicated cell for basic research
to understand features of the covid-19 epidemic in India.

STATEMENT OF THE PROBLEM

A Study to assess the effectiveness of structured teaching

programme on knowledge regarding selected aspect of COVID-19
among children in selected Sharay khema Munshiganj Amethi.

.
OBJECTIVES

Assess the existing level of knowledge on selected aspect of

children on COVID – 19.

Evaluate the effectiveness of structured teaching programme on

knowledge regarding
Covid 19 among children.
Associate the level of knowledge.

HYPOTHESIS
 H1-There significant difference between pre-test and post-test level
of knowledge
regarding select aspects of COVID-19 among children.

H2-There will be association between level of knowledge with

the selected
demographic variables among children.

ASSUMPTION-

Children may have inadequate level of knowledge regarding selected

aspect of COVID-
19 among children.
Level of knowledge among children may vary with their selected
socio demographic
variable.

OPERATIONAL DEFINITION
EFFECTIVENESS-
It refers to improve the knowledge regarding COVID-19 among
children after
administration.
STRUCTURED TEACHING PROGRAMME

It refers to systematically developed instructional aid designed for

children on aspects
of Covid-19.

Introduction of covid-1
Definition of Covid
Causative agent of Covid -19
Sign and Symptoms of covid-19
Diagnostic evaluation of covid-19
Prevention of covid-19
Management of covid-19
Health education
 CHAPTER-II

REVIEW OF LITERATURE
 Abbas K, Procter SR, Sandwort K, et al. Routine childhood
immunisation during
COVID-19 pandemic in Africa: a benefit-risk analysis of health benefits
versus excess
risk of SARS-CoV-2 infection. Lancet Glob Health 2020 (published
online Jul 17)

Abu-Raddad LJ, Chemaitelly H, Bitt AA, for the National Study

Group for COVID-19 Vaccination. Effectiveness of the BNT162b2
Covid-19 vaccine against the B.1.1.7 and B.1.351 variants. N Engl J
Med (Correspondence) 2021 (published online May 5)

Adegunsoye A, Ventura IB, Liarski VM. Association of Black race

with outcomes in COVID-19 disease: a retrospective cohort study. Ann
Am Thorac Soc 2020 (published online Jul 9)

Advani SD, Baker E, Cromer A, et al. Assessing SARS-CoV-2

preparedness in US community hospitals: a forgotten entity. Infect
Control Hosp Epidemiol 2020 Oct:1-16

Afshar Y, Gaw SL, Flaherman VJ, et al. Clinical presentation of

coronavirus disease 2019 (COVID-19) in pregnant and recently
pregnant people. Obstet Gynecol 2020 (published online Oct 7)

Ahmad K, Erquo S, Shah N, et al. Association of poor housing

conditions with COVID-19 incidence and mortality across US counties.
PLoS One 2020 (published online Nov 2)

Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-

acute sequalae of COVID-19. Nature 2021 (published online Apr 22)

Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-

acute sequalae of COVID-19. Nature 2021 (published online Apr 22)

Ali ST, Wang L, Lau EH, et al. Serial interval of SARS-CoV-2 was
shortened over time
by nonpharmaceutical interventions. Science 2020 (published online Jul
21)
VIEW AT Science

Allotey J, Stallings E, Bonet M, et al. Clinical manifestations, risk

factors, and maternal
and perinatal outcomes of coronavirus disease 2019 in pregnancy: living
systematic
review and meta-analysis. BMJ 2020 Sep 1;370:m3320

Althoff KN, Schlueter DJ, Anton-Culver H, et al. Antibodies to

SARS-CoV-2 in All of Us research program participants, January 2–
March 18, 2020. Clin Infect Dis 2021 (published online Jun 15

Alvarez-Garcia J, Jaladanki S, Rivas-Lasarte M, et al. New heart

failure diagnoses among patients hospitalized for COVID-19. J Am Coll
Cardiol 2021 May;77(17):2260

Alves D, Curvello R, Henderson E, et al. Rapid gel card agglutination

assays for serological analysis following SARS-CoV-2 infection in
humans. ACS Sens 2020 (published online Jul 16)

Amit S, Regev-Yochay G, Afek A, et al. Early rate reductions of

SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine
recipients. Lancet (Letter) 2021 (published online Feb 18)

Anand S, Montez-Rath M, Han J, et al. Prevalence of SARS-CoV-2

antibodies in a large nationwide sample of patients on dialysis in the
USA: a cross-sectional study. Lancet 2020 (published online Sep 25)

Anderson EJ, Rouphael NG, Widge AT, et al. Safety and

immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults.
N Engl J Med 2020 (published online Sep 29)

Anesi GL, Jablonski J, Harhay MO, et al. Characteristics, outcomes,

and trends of patients with COVID-19–related critical illness at a
learning health system in the United States. Ann Intern Med 2021
(published online Jan 19)

Angulo FJ, Finelli L, Swerdlow DL. Estimation of US SARS-CoV-2

infections, symptomatic infections, hospitalizations, and deaths using
seroprevalence surveys. JAMA Netw Open 2021 Jan 5;4(1):e 2033706

Aran D, Beachler DC, Lanes S, et al. Prior presumed coronavirus

infection reduces COVID-19 risk: a cohort study. J Infect 2020
(published online Oct 27)

Arnold FW, Bishop S, Oppy L, et al. Surveillance testing reveals a

significant proportion of hospitalized patients with SARS-CoV-2 are
asymptomatic. Am J Infect Control 2021 (published online Jan 8)

Arolas HP, Acosta E, Lopez-Casasnovas G, et al. Years of life lost to

COVID-19 in 81 countries. Sci Rep 2021 Feb 18;11:3504
VIEW AT Sci Rep
Arrazola J, Masiello MM, Joshi S, et al. COVID-19 mortality among
American Indian and Alaska Native persons—14 states, January–June
2020. MMWR 2020 Dec 11;69(49):1853-6

Atherstone C, Peterson ML, Malone M, et al. Time from start of

quarantine to SARS-CoV-2 positive test among quarantined college and
university athletes—7 states, June-October 2020. MMWR 2021 Jan
8;70(1):7-11

Audi A, Al Ibrahim, Kaddoura M, et al. Seasonality of respiratory

viral infections: will COVID-19 follow suit? Front Public Health 2020
(published online Sep 15)

Aveyard P, Gao M, Lindson N, et al. Association between pre-existing

respiratory disease and its treatment, and severe COVID-19: a
population cohort study. Lancet Respir Med 2021 (published online Apr
1)

Ayoubkhani D, Khunti K, Nafilyan V, et al. Post-COVID syndrome

in incdividuals admitted to hospital with COVID-19: retrospective
cohort study. BMJ 2021 Mar 31;372:n693

Baden LR, El Sahly HM, Essink B, et al. Efficacy and safety of the
mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med 2020 (published
online Dec 30)

Badr H, Du H, Marshall M, et al. Association between mobility

patterns and COVID-19 transmission in the USA: a mathematical
modelling study. Lancet Infect Dis 2020 (published online Jul 1)

Bahar B, Jacquot C, Mo YD, et al. Kinetics of viral clearance and

antibody production across age groups in SARS-CoV-2 infected
children. J Pediatr 2020 (published online Sep 3)

Bahl P, de Silva C, Bhattacharjee S, et al. Droplets and aerosols

generated by singing and the risk of COVID-19 for choirs. Clin Infect
Dis 2020 (published online Sep 12

Bajema KL, Wiegand RE, Cuffe K, et al. Estimated SARS-CoV-2

seroprevalence in the US as of September 2020. JAMA Intern Med 2020
(published online Nov 24)

Bampoe S, Lucas DN, Neall G, et al. A cross‐sectional study of

immune seroconversion to SARS‐CoV‐2 in frontline maternity health
professionals. Anaesthesia 2020 (pubslihed online Aug 10)
Barbaro RP, MacLaren G, Boonstra P, et al. Extracorporeal
membrane oxygenation support in COVID-19: an international cohort
study of the Extracorporeal Life Support Organization registry. Lancet
2020 (published online Sep 25)

Barboza JJ, Chambergo-Michilot D, Velasquez-Sotomayor M, et al.

Assessment and management of asymptomatic COVID-19 infection: a
systematic review. Travel Med Infect Dis 2021 (published online Apr 7)

Barham HP, Tha MA, Broyles S, et al. Association between bitter

taste receptor phenotype and clinical outcomes among patients with
COVID-19. JAMA Netw Open 2021 May 25;1;4(5):e2111410

Barnkob MB, Pottegard A, Stovring H, et al. Reduced prevalence of

SARS-CoV-2 infection in ABO blood group O. Blood Adv 2020 Oct
14;4(20):4990-

Barry V, Dasgupta S, Weller DL, et al. Patterns in COVID-19

vaccination coverage, by social vulnerability and urbanicity—United
States, December 14, 2020–May 1, 2021. MMWR May 28;70

Basavaraju SV, Patton ME, Grimm K, et al. Serologic testing of U.S.

blood donations to identify SARS-CoV-2-reactive antibodies: December
2019-January 2020. Clin Infect Dis 2020 (published online Nov 30)

Bassett MT, Chen JT, Krieger N. Variation in racial/ethnic disparities

in COVID-19 mortality by age in the United States: a cross-sectional
study. PLoS Med 2020 (published online Oct 20)

Bassolas A, Sousa S, Nicosia V. Diffusion segregation and the

disproportionate incidence of COVID-19 in African American
communities. J R Soc Interface 2021 (published online Jan 27)

Bastos ML, Periman-Arrow S, Menzies D, et al. The sensitivity and

costs of testing for SARS-CoV-2 infection with saliva versus
nasopharyngeal swabs. Ann Intern Med 2021 (published online Jan 12)

Bellino S, Punzo O, Rota MC, et al. COVID-19 disease severity risk

factors for pediatric patients in Italy. Pediatrics 2020 Jul:320200009300

Bellon M, Baggio S, Bausch FJ, et al. SARS-CoV-2 viral load kinetics

in symptomatic children, adolescents and adults. Clin Infect Dis 2021
(published online May 5)

Beovic B, Dousak M, Ferreira-Coimbra J, et al. Antibiotic use in

patients with COVID-19: a 'snapshot' Infectious Diseases International
Research Initiative (ID-IRI) survey. J Antimicrob Chemother 2020
(published online Aug 7)

Berenguer J, Ryan P, Rodriguez-Bano J, et al. Characteristics and

predictors of death among 4,035 consecutively hospitalized patients
with COVID-19 in Spain. Clin Microbiol Infect 2020 (published online
Aug

Berg MK, Yu Q, Salvador CE, et al. Mandated Bacillus Calmette-

Guerin (BCG) vaccination predicts flattened curves for the spread of
COVID-19. Sci Adv 2020 (published online Jul 31)

Bergman A, Sella Y, Agre P, et al. Oscillations in U.S. COVID-19

incidence and mortality date reflect diagnostic and reporting factors.
mSystems 2020 Jul/Aug;5(4):e00544-20

Bernal JL, Andrews N, Gower C, et al. Early effectiveness of

COVID-19 vaccination with BNT162b2 mRNA vaccine and ChAdOx1
adenovirus vector vaccine on symptomatic disease, hospitalisations and
mortality in older adults in the UK: a test negative case control study.
Public Health England (preprint) 2021

Bhatla A, Mayer MM, Adusumalli S, et al. COVID-19 and cardiac

arrhythmias. Heart Rhythm 2020 (published online Jun 22)

Bilal U, Tabb LP, Barber S, et al. Spatial inequities in COVID-19

testing, positivity, confirmed cases, and mortality in 3 U.S. cities. Ann
Intern Med 2021 (published online Mar 30)

Binder RA, Alarja HA, Robie ER, et al. Environmental and

aerosolized SARS-CoV-2 among hospitalized COVID-19 patients. J
Infect Dis 2020 (published online Sep 9)

Birgand G, Peiffer-Smadja N, Fournier S, et al. Assessment of air

contamination by SARS-CoV-2 in hospital settings. JAMA Netw Open
2020 Dec 23;3(12):e2033232

Birhane M, Bressler S, Chang G, et al, for the CDC COVID-19

Vaccine Breakthrough Case Investigations Team. COVID-19 vaccine
breakthrough infections reported to CDC—United States, January 1–
April 30, 2021. MMWR 2021 May 25;70

Bixler D, Miller AD, Mattison CP, et al. SARS-CoV–2 associated

deaths among persons aged <21 years—United States, February 12–July
31, 2020. MMWR 2020 Sep 15;69
VIEW AT MMWR
Blackburn J, Yiannoutsos CT, Carroll AE, et al. Infection fatality
ratios for COVID-19 among noninstitutionalized persons 12 and older:
results of a random-sample prevalence study. Ann Intern Med (Letter)
2020 (published online Sep 2)
 Chapter III

RESEARCH METHODOLOGY

RESEARCH APPROACH- Quantitative research approach

RESEARCH DESIGN- Pre- experimental (one group pre test, post
test research design.
RESEARCH SETTING- Munshiganj ,Amethi Uttar pradesh
TARGET POPULATION-Children (6-12)
SAMPLE&SAMPLING TECHNIQUES-Convenience sampling
technique

RESEARCH VARIABLES

INDEPENDENT VARIABLES-
A Structured teaching programme on Selected aspects of Covid-19.
DEPENDENT VARIABLES-
Effectiveness of Structured Teaching Programme on knowledge
regarding selected
Aspect of COVID-19 among children.

DEMOGRAPHIC VARIABLES-In this study demographic variables

are age,
class, previous knowledge, Parents education, occupation of father,
occupation of
mother, parent’s income.

SAMPLE SELECTION CRITERIA

INCLUSION CRITERIA

Children who will between the age of 12-17 years.

Children who are interested during data collection.

EXCLUSION CRITERIA-
Children who will absent at the time of data collection.
Who will not interested in the participating.
 POPULATION-
All children those full-fill the inclusion criteria and studied in selected
college

SETTING-
Sharay khema Munshiganj Amethi Uttar Pradesh

SAMPLE-s
Selected children of Sharay Khema at Munshiganj Amethi.

SAMPLE SIZE-30 children.

METHOD OF DATA COLLECTIONS

Data will be collected by self structured questionnaire.

PHASE-1 Pre-test assessment of level of knowledge.

PHASE-2 Structured teaching programme implementation on the
same group.

PHASE-3 Post test assessment of same group after 7 days.

RESEARCH TOOLSs

SECTION-1
Demographic variables consist of age, class, previous knowledge,
parents
education, occupation of father, occupation of mother, parent’s
income.

SECTION-2
Self-structured questionnaire consist of 30 questions related to
selected aspects of
COVID-19.
DATA ANALYSIS
DESCRIPTIVE ANALYSIS-
Percentage distribution, mean, standard deviation will be use to
analysis the data.

INFERENTIAL ANALYSIS-
Non parametric test.
 Chi square test will be use to analysis the inferential
statistic

CHAPTER –IV
RESULTS
Objective -1: Assessment of the demographic variable of the children.
Table-1: Demographic variable of the children.
S/N. Demographic Percentage(%)
Variable Number
1. Age of the children

A- 6 to 8 year. 7 23.3%
B- 9 to 10 year. 9 30%
C- 11 to 12 year. 14 46.6%
2. Gender of children
A- Male. 15 50%
B- Female. 15 50%

3. Previous knowledge
A. Newspaper. 5 16.6%
B. Television. 19 63.6%
 C. Social interaction. 6 20%

4. Parents education
A. Illiterate. 13 43.3%
B. Primary education. 17 56.6%
C. Secondary 0 0%
education. 0 0%
D. Degree/Diploma.
5. Parents education
A. Housewife and 22 73.3%
farmer. 0 0%
B. Businessman. 8 26.6%
C. Labor 0 0%
D. Government job.

TABLE-1: SHOWS THAT DEMOGRAPHIC VARIABLES OF

CHILDREN.
In age of children- The majority of them 14(46.6%) belong to age children 11
to 12 years, 19(30%) belong to 9 to 10 year, 7(23.3) belong to 6 to 8 year.
In gender of children- Male -15 (50%)
Female -15 (50%).
In previous knowledge of children- The majority of them 19(63.6%) belong
to television, 6(20%) belong to belong to social interaction, 5(16.6) belong to
newspaper and books.
In education of children parents – The majority of them 17(56.6%) belong to
primary education, 13(43.3%) belong to illiterate.
In occupation of children of parents –The majority of them 22(73.3%)
belong to house wife and farmer, 8(26.6%) belong to labor.
 AGE

46.60%

30%
23.30%

6 -8 yrs 9-10 yrs 11-12 yrs

Figure-1.Percentage distribution of age of the children in year

Gender

50% 50%
50%

40%

30%

20%

10%

0%
Male Female

Fig-2. Percentage distribution of gender

 Previous Knowledge

63.60%
70.00%
60.00%
50.00%
40.00%
30.00% 20%
16.60%
20.00%
10.00%
0.00%
Newspaper and Television Social
books

Fig-3. Percentage distribution of previous knowledge of the children

Parents Education

56.60%
60.00%

50.00% 43.30%

40.00%

30.00%

20.00%

10.00% 0% 0%
0.00%
Illitarate Primary Secondary Degree/Diploma
Education Education

Fig-4. Percentage distribution of parents educaton

 Parents occupation

73.30%
80.00%
70.00%
60.00%
50.00%
40.00% 26.60%
30.00%
20.00%
10.00% 0% 0%
0.00%
Housewife and Buisinessman Labour Government job
former

Fig-5. Percentage distribution of parents occupation

TABLE -2- To assess level of pretest knowledge on covid-19 among

children.

LEVEL OF SCORE NUMBER PERCENTAGE

KNOWLEDGE
Inadequate <50 25 83.33%
Moderate 50 to 70 5 16.66%
Adequate >70 0 0%

Total 30 99.99%

Table- 2:- Show that assessment of pre- test level of knowledge regarding
COVID-19 in the majority of them 0(0%) belong to adequate knowledge,
25(83.33%) to inadequate knowledge, 5(16.66%) belong to moderate
knowledge.

TABLE -3- TO ASSESS POST KNOWLEDGE SCORE ON COVID-19

AMONG CHILDREN.
LEVEL OF SCORE NUMBER PERCENTAGE
KNOWLEDGE
Inadequate <50 5 16.66%
Moderate 50 to 70 9 30%
Adequate >70 16 53.33%

Total 30% 100%

Table -3:- Shows that assessment of post –test level of knowledge regarding
COVID-19 in that majority of them 16(53.33) belong to adequate knowledge,
5(16.66%) belong to inadequate knowledge and 9(30%) belong to moderate
knowledge.
OBJECTIVESS- To evaluate the effectiveness of structured teaching program
on COVID-19 among children.
TABLE-4:- ECTIVNESS OF STRUCTURED TEACHING PROGRAME
ON KNOWLEDGE REGARDING COVID-19 AMONG CHILDREN.
DOMAIN MEAN STANDARD t-test
DEVIATION
Pre-test 11.8 2.84
Post-test 11.83 15.34 +=12.89

Table-4:-shows effectiveness of structured teaching program of knowledge on

COVID-19 among children in that mean is 11.8 and 17.83, standard deviation
is 2.84 and 15.34 and t-test value was 12.89 representing.
 CHAPTER – V

DISCUSSION
A study assesses the effectiveness of structured teaching program on
knowledge regarding COVID-19 among children under the age of 6 to 12 year
at selected community.
The research was conducted to assess the knowledge regarding COVID-19
among children in selected community Amethi. In order to achieve the
objective of the study an experimental Pretest –Posttest design was adopted.
Simple random sampling technique was used to select the sample.
The data was collected from selected 30 selected sample. the finding of the
study has been discussed with reference to the objective and hypothesis and
with other findings of other studies.
Characteristics of demographic variable-
Description of demographic variables revealed that out of 30 majority of the
children age 7(23.3%) belong 6 to 8 year, (30%) belong to 9 to 10 year
,14(46.6%) belong to 11 to 12 year with regards to gender of children a
majority of them.
With regards to previous knowledge of children a majority of them
15(63.6%)belong to television ,06(20%) belong to social group ,05(16.6)
belong to newspaper and book .
With regards to parents education the majority of them 17(56.5%) belong to
primary education ,13(43.3%) belong to secondary education.
With regards to parents occupation 22(73.3) belong to housewife and farmer
,8(26.6%) belong to labour .
Limitations-
The study was limited to 30 sample .
The study was limited to sample from community area .

CHAPTER –VI
CONCLUSION
The study of knowledge regarding COVID -19 among children at selected community
Amethi. the result there was inadequate knowledge.
The results reveals that majority of them are 25(83.33%) belong to inadequate
knowledge and 5(16.66%) belong to moderate knowledge there was statically
significant association of knowledge regarding COVID-19 among children age under
6 to 12 year with their selected demographic variable such as –Age and parent’s
education.
On the basis of the findings conclusion are made-
The analysis reveal that the overall mean score was 06.6 with the mean percentage of
20%. It was found that there is significant positive correlation between knowledge
regarding COVID -19 among children under the of 6 to 12
Implementations-
The results of study previous the children have inadequate knowledge regarding
COVID -19 among children under the age of 6 to 12 year.
Hens the student should be given education with the help, improving their knowledge.
Finding of study.
Nursing practice-
Nursing should periodical help education to children regarding COVID-19 among
children.
Nurse can form and formulae guidelines on COVID -19 among children under the age
of 6 to 12 years.
All nurse should be providing training to improve knowledge about prevention and
management of COVID -19 among children.
Nursing education-
This study emphasis on improving knowledge regarding COVID -19 To improve their
confidence in order to achieve this degree and diploma programme should be includes
multiple to maintain the knowledge on care of COVID - 19.
Nursing Administration
Nursing administration authorities should initiate possible mechanism to enhance the
quality of care at selected community Amethi.
The community health nurse and system of good care methods.
The community health nurse should facilitate to adequate number of book and
pamphlet in children. On study will help the community health nurse to develop
protocol regarding COVID-19.

Nursing Research –
It will enhance knowledge about caring of children. this study will serve as available
reference material for future.
A large scale can be conducted.

CHAPTER-VII
SUMMERY
A study to assess the effectiveness of structured teaching programme on knowledge
regarding COVID-19 among children under the age of 6 to 12 year in selected
community area Munshiganj.
Objective of the study –
To determine the effectiveness of COVID-19 disease at the selected community area.
To determine the knowledge level of student regarding COVID -19.
To assess the pre- test knowledge regarding COVID-19.
To assess the post – test knowledge regarding COVID-19 among children.
To find out difference between pretest and post- test.
Hypothesis-
H-1-There is a significant association between the knowledge and attitude among the
student with their selected area community.
H-2-There is significant difference between pretest and post- test knowledge
regardingCOVID-19 among children in selected community area.
Major finding of study were-
A majority of the age of the children majority of them 14(46.6%) belong to age 10-12
year,19(30%) belong to age 9 to 10 year, 7 ( 2 3.3%) belong to age 6to8 year.
The majority of regards the gender of children both having 50-50%, the male belong
15(50%) and female belong to 15(50%).
The majority of regards to previous knowledge of children 19(63.60%)belong to
television ,6(20%) belong to social interaction ,5(16.6%)belong to newspaper and
books.
The majority of education of the parents 17(56.6%) belong to primary education and
13(43.3%) belong to illiterate.
The majority occupation of parents of them 22(73.3%) belong to house wife and
farmer ,8(26.6%) belong to labour.

BIBLIOGRAPHY

Huang etal” clinical feature of patients infected with 2019 novel

coronavirus in Wuhan china, lancet vol 395 no 10223, pp 497
506,2020
World health organization coronavirus disease 2019(covid 19)”
situate report 73 vol. 2019, no April,pp.1-19,2020

G.P.T COVID -19, “Home Covid-19 go-id “ Gugus Tugas

Penagnan Covid-19 2020 (online)
Available:https;//www.Covid19.go-id [Accessed: 03-april-2020]

A Riedel S.Morse,S mietznert miller S. Jawetz,Melrick,Medical

microbiological 28th newyork 2019

N. Zhu et al.” A novel corona vaccine from patients with

Pneumonia in China 2019,” N. Engl J.Med. vol.382,no 8, pp 727-
733-2020

A.E. Gorbuleny a et al, the species severe acute respiratory

systematic related corona vaccine classifying 2019-n cov and
Naming it SARS-Cov-2’’Nat Microbiol, no box 1,2020

P. Zhou et al,” A pneumonia outwork associated with a new corona

vaccine of problem bat origin,’ ’Nature, vol 579 no 7798 , pp ,270-
273,2020

T. Zhang q.wu,ana Z. Zhang ‘’problem Pangolin origin of 2019-n

cov associated with outbreak of covid 19 SSRN Library,pp1-
6,2020

H Zhong j. M pregnancy, .Li, N ,Zhong ,and A,S,S

LESTSKY,Angiotensin-converting enzyme2 (ACE2) As a SARS-
COV-receptor ; molecular mechanism and potential therapeutic
target,”intensive care med,vol.2,2020

Y, Liv , A.A. Gayle ,A. Wilder-smith ,and J, Rocklov ,The

reproductive number of covid -19 is higher compared to SARS
Corona vaccine ,’’J. Travel Med, no February pp1-6,2020

Y. Han and H. Yang,’’ the transmission and diagnosis of 2019

novel corona vaccine infection disease ( covid 19),A
Et al van December N, Bus maker Morris DH, Holbrook MG
gamble A,Wiliomson BN,’’ aerosol and surface stability of SARS
COVID -2 as compared with SARS COV-1,’’N.Engl.S.med.pp 1-
3,2020

D.M Yan Bai Qingshang Yao, Tawe, Fithian, Dong Yan Jin,
Lijvan Chen,’’ prascemend asymptomatic earlier transmission of
covid 19,’’AM.med associated pp 1-2,2020

De witan. Tang x Zhang Y. Lies,x.Li. and H. Shan, ’Evidence for

GI infection of SARS-COV 2 Gastrointestinal,2020

E. De wit, Niven Doremalen,D, D, falzarano and V.G

munster,’’SARS and MERS: recent insight in to emerging
coronavirus, not rev. Microbial vol.14 no 8pp523-534,2016

Y.Lies et al .Aerodynamic characteristic and RNA concentration of

SARS cov-2 aerosal in Wuhan hospital during covid -19
outbreak,’’bioRxiv,vol,86 no 21 pp 2020

R.Tellier,Y.Li ,B.J.Cowling EJ.W.Tang ‘’reorganization of aerosol

transmission of infection agents ;A commentary,’’BMC infect
Dis,vol .19 no 1 pp 1-92019
 Section-A
1.Age in years :-
a) 6-8 yr. [ ]
b) 9-10 yr. [ ]
c) 11-12 yr [ ]

2.Gender:-
a) Male [ ]
b) Female [ ]

3.Previous knowledge regarding covid-19:-

a) Newspaper or book [ ]
b) Mass media [ ]
c) Social communication [ ]

4.Parent’s education
a) Mother [ ]
b) Father [ ]

5.Occupation of Parent’s
a) Mother [ ]
b) Father [ ]Section-B

General Information Related to Covid-19

1.What is Coronavirus?
A. It is a large family of virus. [ ]
B. It belong from to the family of Nidovirus. [ ]
C. Both A and B. [ ]
D. Only A is correct. [ ]

2.In which coronavirus was identified first timeA. 2019 [ ]

B. 2018 [ ]
C. 2017 [ ]
D. 2020 [ ]

3.The “coronavirus” disease is named given by:-

A. UNICEF [ ]
B. WHO [ ]
C. RCA [ ]
D. FAO [ ]

4.The first cause Novel coronavirus was identified in:-

A. Beijng [ ]
B. Wuhan,Hubei [ ]
C. Shanghai [ ]
D. Jianjin [ ]

5.Full form SARS:-

A.Severe acute Respiratory syndrome [ ]
B.Severe acute Renal syndrome [ ]
C.Severe Respiratory acute system [ ]
D.Severe Arrested Respiratory system [ ]

6.Covid-19 is:-
A. Viral infectious disease [ ]
B. Fungal infectious disease [ ]
C.Bacterial infectious disease [ ]
D.Protozoal infectious disease [ ]

7.Covid-19 which types of disease: -

A. Non communicable [ ]
B. Communicable [ ]
C.A and B both [ ]
D.None of these [ ]

8.How many countries areas or territories are suffering from Noval

coronavirus
outbreak in the world.
A. More than 50 [ ]
B. More than 200 [ ]
C.More than 100 [ ]
D.More than 150 [ ]

9.In which age group the covid-19 separate

A. Covid-19 occur in all age groups [ ]
B. Coronavirus infection is mild in children [ ]
C.Older person and person with medical condition at high risk to develop
serious illness [ ]
D.All of the above are correct [ ]

10.Which of following disease related to coronavirus

A. SAERS [ ]
B. SERS [ ]
C.SARS [ ]
D.SARRS [ ]

Causes of covid-19:-

11.Covid-19 caused byA.Herpes Simplex virus [ ]

B .Retrovirus [ ]
C.Paravirus [ ]
D.Coronavirus [ ]

12.Mode of transmission of coronavirus: -

A. Droplet transmission [ ]
B. Direct transmission [ ]
C.Indirect transmission [ ]
D.None of the above [ ]

13.Incubation period of covid-19:-

A.14 days [ ]
B.10 days [ ]
C.7 days [ ]
D.12 days [ ]

14.Risk factors of covid -19

A. Unhygienic condition [ ]
B. Children and old age person(immunocompromised) [ ]
C. Contact with infected person [ ]
D. All of the above [ ]

15.How does coronavirus transmit?

A. when a person sneezes or cough,droplets spread in the air [ ]
B. Contact with infected person [ ]
C. Touch the infected surface and further touch mouth,nose and he or she
get infection [ ]
D. All of above correct [ ]

Sign and Symptoms

16.Mild symptom of covid 19 disease ?
A. Fever [ ]
B. Shortness of breath [ ]
C. Cough [ ]
D. All of the above. [ ]

17. Corona virus affect mainly which system?

A. Genitourinary system [ ]
B. Respiratory system [ ]
C. GI system [ ]
D.Cardiovascular system [ ]

18. Corona virus mainly affect which organs?

A. Lungs [ ]
B. Kidney [ ]
C. Liver [ ]
D. Stomach [ ]Diagnostic Evaluation

19.Covid-19 are diagnosed by-

A. CBC [Complete blood count] [ ]
B. Chest x-ray [ ]
C. Chest CT Scan [ ]
D. All of the above [ ]

20. Which test used for covid-19, NameA.HIV test [ ]

B. ALISA test [ ]
C. Combo test [ ]
D. BIDAL test [ ]

21.For covid-19 specimen culture (sample) take from:-

A. Nasopharangeal or pharangeal swab [ ]
B. Liver tissue culture [ ]
C. Spleen tissue culture [ ]
D. Kidney tissue culture [ ]

Management

22.Thailand announced that it has proceeded to test its novel coronavirus

vaccine on which animal/bird ?
A. Monkey [ ]
B. Hens [ ]
C. Dog [ ]
D. Kites [ ]

23.Name a clinical trial in which blood is transfused from recovered

covid-19 pt.to
a coronavirus pt.who is in critical condition?
A. Plasma therapy [ ]
B. Chemotherapy [ ]
C. Radiation therapy [ ]
D.Gene therapy [ ]

24.Name of Covid vaccine: -

A. TT vaccine [ ]
B. Hib Vaccine [ ]
C. Polio vaccine [ ]
D. Covid-sheald vaccine [ ]

25.Which covid-19 drugs launched by Indian Pharmacists:-

A. Fauipirauir [ ]
B. PNT162 [ ]
C. PICOVACC [ ]
D. All of the above[ ]Prevention

26.What are the precautions that need to be taken to protect from the
coronavirus:-
A. Cover your nose and mouth when sneezing [ ]
B. Add more qarlic in your diet [ ]
C. Visit your doctors for antibiotics [ ]
D. None of the above [ ]

27.If any person affected from covid-19, so how many meter/feet distance
need for
prevent transmitted infection.
A. 6 feet(2 meter) [ ]
B. 9 feet(3 meter) [ ]
C. 3 feet(1 meter) [ ]s
 SECTION-A

1. वर्षों में: -

a) 6-8 वर्षष [ ]

b) 9-10 साल [ ]

c) 11-12 साल [ ]

2.Gender: -

a) एक पु रुर्ष [ ]

b) महिला [ ]

3)कोहवद -19 के बारे में स्पष्ट ज्ञान: -

a) समाचार पत्र या पु स्तक [ ]

b) मास मीहिया [ ]

c) सामाहिक संचार [ ]

4.पार्टें र्ट की हिक्षा

a) मााँ [ ]

b) हपता []

5.अहििावकों की िती

a) एक मााँ [ ]
b) हपता [ ]

SECTION-B
कोविद -19 से सं बंवित सामान्य जानकारी

1.कोरोनावायरस क्या िै ?

A )यि वायरस का एक बडा पररवार िै । [ ]

B )यि हनिोवायरस के पररवार से िै । [ ]

c) A और B. दोनों [ ]

d)केवल A सिी िै । [ ]

2. हिसमें कोरोनोवायरस की पिचान पिली बार ए। 2019 []

a)2018 [ ]

b)2017 [ ]

c)2020 [ ]

3.कोरोनावायरस" रोग को हकस नाम से िाना िाता िै : -

a) यू हनसेफ [ ]

b) िब्ल्यूएचओ [ ]

c) आरसीए [ ]

d) एफएओ [ ]
4. पिला कारण उपन्यास कोरोनावायरस की पिचान की गई थी: -

a) बे हिंग [ ]

b) वुिान, हुबे ई [ ]

c) िंघाई [ ]

d) हियानहिन [ ]

5 ]पू णष रूप सासष: -

a) Severe acute respiratory syndrome [ ]

b) severe acute renal syndrome [ ]

c) Severe श्वसन तीव्र प्रणाली [ ]

d) Severe हगरफ्तार श्वसन प्रणाली [ ]

6]कोहवद -19 िै : -

a) वायरल संक्रामक रोग [ ]

b) फंगल संक्रामक रोग []

c) बै क्टीररयल संक्रामक रो [ ]

d)Protozoalसंक्रामक रोग [ ]

7] कोहवद -19 हकस प्रकार की बीमारी िै : -

a) संचार योग्य []

b) Communicable []

c)A और B दोनों [ ]

d ) इन में से कोई निीं [ ]

8] हकतने दे िों के क्षेत्र या क्षेत्र नोवल कोरोनावायरस से पीहडत िैं

दु हनया में प्रकोप।

a)50 से अहिक [ ]

b)200 से [ ]

c)100 से अहिक [ ]
d) 150 से अहिक [ ]

9] हकस आयु वगष में कोहवद -19 अलग-अलग िोता िै

a) कोहवद -19 सिी आयु समूिों में िोते िैं []

b) कोरोनोवायरस संक्रमण बच्ों में िल्का िोता िै [ ]

c) बु िुगष व्यक्ति और गं िीर बीमारी के हवकास के हलए उच् िोक्तिम वाले हचहकत्सा क्तथथहत वाले व्यक्ति [ ]

d)उपरोि सिी िी। सिी िैं [ ]

10] कोरोनोवायरस से संबंहित हनम्नहलक्तित बीमारी िै

a) SAERS []

b) SERS []

c) सासष []

d)SARRS []

11]कोहवद -19 के कारण: -

a) िर्ल्ष हसम्प्लेक्स वायरस के कारण िोता िै []

b) र्टरॉर्टर वायरस []

c)पारावायरस []

d)कोरोनोवायरस []

12] कोरोनावायरस के संचरण का: -

a) िर ॉपलेर्ट र्टरां सहमिन []

b) अप्रत्यक्ष संचरण []

c)अप्रत्यक्ष संचरण []

d)उपरोि में से कोई निीं []

13] कोहवद -19 की अं तर्ग्ष िण अवहि: -

a)14 हदन []

b)10 हदन []

c)7 हदन []
d)12 हदन []

14] Rov कारकों के कोहवद -19

a) अनैक्तिक क्तथथहत []

b) बच्े और बू ढे व्यक्ति (प्रहतरक्षाहविीन) []

c) संक्रहमत व्यक्ति से संपकष करें [ ]

d) उपरोि सिी [ ]

15] कोरोनोवायरस कैसे संचाररत िोता िै ?

a) िब कोई व्यक्ति छींकता िै या िां सी करता िै , तो बूं दे िवा में फैल िाती िैं []

b) संक्रहमत व्यक्ति से संपकष करें [ ]

c) संक्रहमत सति को स्पिष करें और आगे मुंि, नाक को स्पिष करें और उसे संक्रमण िो िाए [ ]

d) उपरोि सिी सिी []

सं केत और लक्षण

16] कोहवद 19 बीमारी के लक्षण?

a) एक बु िार [ ]

b) सां स की तकलीफ []

c) कफ []

d) उपरोि सिी। []

17] कोरोना वायरस मुख्य रूप से हकस प्रणाली को प्रिाहवत करता िै ?

A )वंिावली प्रणाली []

b) श्वसन प्रणाली []

c) िी.आई प्रणाली []

d) काहिष योवास्कुलर हसस्टम []

18] कोरोना वायरस मुख्य रूप से हकन अं गों को प्रिाहवत करता िै ?

a) फेफडे []

b) हकिनी []

c) हलवर []

d) पे र्ट []

19]कोहवद -19 द्वारा हनदान हकया िाना िै -

a) सीबीसी [पू णष रि गणना] []

b) चेस्ट एक्स-रे []

c) चेस्ट सीर्टी स्कैन []

d) उपरोि सिी [ ]

20] कोहवद -19 के हलए हकस परीक्षण का उपयोग हकया गया, नाम

A) HIV परीक्षण []

b) एहलसा परीक्षण []

c) कॉम्बो परीक्षण []

d) हबिाल परीक्षण [ ]

21] कोहवद -19 नमूना संस्कृहत (नमूना) से लेते िैं : -

a) नासोफ्ां हगयल या फैरें हियल स्वाब []

b) हिगर ऊतक संस्कृहत []

c)हतल्ली हर्टिू कल्चर []

d) हकिनी हर्टिू कल्चर []

प्रबंि

22] थाईलैंि ने घोर्षणा की हक वि अपने उपन्यास कोरोनावायरस वैक्सीन का परीक्षण करने के हलए आगे
बढा िै

हकस पिु / पक्षी पर?

a) बन्दर [ ]

b) िीन्स []
c) िॉग []

d)काइर्ट् स []

23] कोई नैदाहनक परीक्षण न करें हिसमें रि बरामद कोहवद -19 pt.to से र्टरां सफ़्यू ज़ हकया गया िो

कोरोनोवायरस pt.who गं िीर क्तथथहत में िै ?

a) लाज्मा थेरेपी []

b) कीमोथेरेपी []

c) हवहकरण हचहकत्सा []

d)Geneथेरेपी []

24] कोहवद र्टीका का नाम: -

a) र्टीर्टी र्टीका []

b) हिब वैक्सीन []
 STRUCTURED TEACHING PLAN ON COVID –
19

Name of the student teacher- Miss. Annapurna Yadav, Miss Nidhi Shukla, Pooja Yadav,
Poonam

Pal

Subject - Research

Topic - COVID 19

Number of the members - 30

Time - 45 min

Venue - community area

Method of teaching - Lecture cum discussion

General objective - At the end of the class the patient will acquired adequate
knowledge

Regarding COVID - 19 and its prevention.

Specific objective -At the end of session the group will able to-

-Understand introduction of covid19.

-Describe definition of COVID-19.

-In list causes and clinical features.

- List down diagnostic evaluation.

-Explain about management.

-Explain about prevention.

S/N time Specific Content method AV aids Evaluation

objective
1. 8min To INTRODUCTION-Corona is a Lecture ----- What is
. Introduce spreading Globally but important corona virus?
The is to take necessary measures.
COVID-19. Corona virus disease is named by
the WHO on 11Feb 2020 a COVID-
19.
Corona Virus are a large family
virus that cause illness ranging
from common cold severe disease.
Such as –Respiratory syndrome
and severe acute Respiratory
Syndrome.
To define Corona is comes from ‘’Latin’’ Define Covid
2. the Word means ‘’HALO or CROWN’’. Lecture 19?
3min COVID-19.
. Definition- COVID-19 is a viral
infectious communicable disease.
It mainly affects Respiratory
system.
3. 2min To in list Causative agent-corona virus Lecture Leaflets Name of the
. causes of Other risk factor – causative
COVID-19. Unhygienic condition. agents?
Contact with infected person.
Immunosuppressed person, etc.
Mode of transmission-
Droplet and direct contact.
To in list Tell about
4. clinical Clinical feature- Lecture Chart clinical
5min feature of -fever. feature?
. COVID- -cough.
19. -fatigue.
-shortness of breath.
-sore throat.
-headache.
-cough with sputum.
Diagnostic evaluation-
5. Diagnostic -History collection. Tell about
Evaluation -Physical examination. Lecture Leaflet. Diagnostic
5min . -CBC. . Evaluation?
. -Chest X-ray.
-PCR.
-Chest CT scan.
-Combo Test.
-Nasopharyngeal and
oropharyngeal
Swab test.

6. Prevention- Are as follows- Book Tell about

-Wash hand with swab. Lecture let. prevention?
To explain -Maintain 1 miter or 6 feet .
5min about distance.
. preventio -Cover nose and mouth from
n of mask.
COVID-19. -Use sanitizer.

7.
Treatment- medicine- Tell any 1
To explain (a)In mild cases-supportive medicine
about treatment. In this include – Lecture name?
5min treatment -Antihistamines and Analgesics
. of COVID- (b)In moderate cases- In this
19. include-
-Hydro chloroquine.
-Ribaum.etc.
(c)In severe cases-In this include-
-oseltamivir
-Ritonavir, etc.
(d)Critical cases-In this include-
-Ribavirin.
 -Osltamivir, etc.
8. Book
Vaccination-Vaccination are- let. Tell the name
To tell Lecture of covid-19
about - Covid-sheald vaccine. . vaccine?
9. vaccinatio Summarization- ------ ---------------
5min n. -Introduction.
. -Definition.
To -Causes. Lecture
summariz -Sign and symptoms.
ed the -Diagnostic evaluation.
7min topic. -Prevention.
. -Treatment.
 BIBLIOGRAPHY

1-COVID-19 and Global food security,www.shlidesh.com

2-Everything about COVID-19, www.human itarin respons.info.

3-Corona virus in India,www.statista.com.